share_log

Needham Maintains Buy on Veracyte, Lowers Price Target to $30

Needham Maintains Buy on Veracyte, Lowers Price Target to $30

Needham维持对Veracyte的买入,将目标价下调至30美元
Benzinga ·  2023/11/08 17:02

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $35 to $30.

Needham分析师迈克·马特森维持Veracyte(纳斯达克股票代码:VCYT)的买入,并将目标股价从35美元下调至30美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发